Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in... see more

Recent & Breaking News (GREY:LXXGQ)

LexaGene to Host Corporate Update on November 3

GlobeNewswire October 26, 2021

LexaGene (TSXV:LXG) completes analytical studies for COVID-19 testing

Julia Kennedy  October 25, 2021

LexaGene Completes Analytical Studies for FDA EUA of COVID-19 Testing

GlobeNewswire October 25, 2021

Small Cap Growth Investor Presentations Now Available for On-Demand Viewing

PR Newswire October 11, 2021

LexaGene's Largest Study Validates Accuracy of its Veterinary Test Panel

GlobeNewswire October 7, 2021

LexaGene to Webcast Live at VirtualInvestorConferences.com October 7th

PR Newswire October 6, 2021

LexaGene Expands Brand Awareness at Key Investor Conferences

GlobeNewswire October 1, 2021

LexaGene Reports on Recent Veterinary Trade Shows

GlobeNewswire September 30, 2021

LexaGene Adopts Corporate Governance Charters and Policies

GlobeNewswire September 17, 2021

LexaGene Enters into Cooperative Research and Development Agreement with the United States Army's Combat Capabilities Development Command

GlobeNewswire September 16, 2021

LexaGene's MiQLab(TM) Accurately Detects Multiple Strains of Pathogenic Bacteria in Polymicrobial Samples Compared to Conventional Culture

GlobeNewswire September 7, 2021

Lexagene Files Preliminary Short Form Base Shelf Prospectus

GlobeNewswire September 3, 2021

LexaGene’s (TSXV:LXG) MiQLab system to be featured at three veterinary tradeshows

John Ballem  September 3, 2021

LexaGene's MiQLab(TM) System Featured at Three Key Veterinary Tradeshows

GlobeNewswire September 3, 2021

LexaGene Demonstrates a Simple and Inexpensive Multiplex PCR Chemistry with Shorter Lead Times for use on its MiQLab System

GlobeNewswire August 12, 2021

LexaGene's MiQLab Detects Common Bioreactor Contaminant up to 300 Times Faster than Conventional Methods

GlobeNewswire July 20, 2021

LexaGene Retains Wolf Greenfield Intellectual Property Law Firm

GlobeNewswire July 14, 2021

LexaGene (TSXV:LXG) launches improved bacterial and drug resistance test for veterinarians

Julia Kennedy  July 7, 2021

LexaGene Launches 2nd Generation Bacterial and Drug Resistance Test to Better Meet the Diagnostic Needs of Veterinarians

GlobeNewswire July 7, 2021

LexaGene (TSXV:LXG) advances toward FDA approval of MiQLab to combat COVID-19

Julia Kennedy  July 2, 2021